OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
(R)-ketamine ameliorates the progression of experimental autoimmune encephalomyelitis in mice
Xingming Wang, Lijia Chang, Yunfei Tan, et al.
Brain Research Bulletin (2021) Vol. 177, pp. 316-323
Open Access | Times Cited: 18
Xingming Wang, Lijia Chang, Yunfei Tan, et al.
Brain Research Bulletin (2021) Vol. 177, pp. 316-323
Open Access | Times Cited: 18
Showing 18 citing articles:
Brain-spleen axis in health and diseases: A review and future perspective
Wei Yan, Tong Wang, Lei Liao, et al.
Brain Research Bulletin (2022) Vol. 182, pp. 130-140
Open Access | Times Cited: 87
Wei Yan, Tong Wang, Lei Liao, et al.
Brain Research Bulletin (2022) Vol. 182, pp. 130-140
Open Access | Times Cited: 87
Arketamine, a new rapid-acting antidepressant: A historical review and future directions
Jichun Zhang, Wei Yao, Kenji Hashimoto
Neuropharmacology (2022) Vol. 218, pp. 109219-109219
Open Access | Times Cited: 69
Jichun Zhang, Wei Yao, Kenji Hashimoto
Neuropharmacology (2022) Vol. 218, pp. 109219-109219
Open Access | Times Cited: 69
(R)-ketamine ameliorates demyelination and facilitates remyelination in cuprizone-treated mice: A role of gut–microbiota–brain axis
Xingming Wang, Lijia Chang, Xiayun Wan, et al.
Neurobiology of Disease (2022) Vol. 165, pp. 105635-105635
Open Access | Times Cited: 52
Xingming Wang, Lijia Chang, Xiayun Wan, et al.
Neurobiology of Disease (2022) Vol. 165, pp. 105635-105635
Open Access | Times Cited: 52
(R)-ketamine as prophylactic and therapeutic drug for neurological disorders: Beyond depression
Xingming Wang, Jianjun Yang, Kenji Hashimoto
Neuroscience & Biobehavioral Reviews (2022) Vol. 139, pp. 104762-104762
Open Access | Times Cited: 41
Xingming Wang, Jianjun Yang, Kenji Hashimoto
Neuroscience & Biobehavioral Reviews (2022) Vol. 139, pp. 104762-104762
Open Access | Times Cited: 41
Targeting Sigma Receptors for the Treatment of Neurodegenerative and Neurodevelopmental Disorders
Dicson Sheeja Malar, Premrutai Thitilertdecha, Kanokphorn S Ruckvongacheep, et al.
CNS Drugs (2023) Vol. 37, Iss. 5, pp. 399-440
Open Access | Times Cited: 32
Dicson Sheeja Malar, Premrutai Thitilertdecha, Kanokphorn S Ruckvongacheep, et al.
CNS Drugs (2023) Vol. 37, Iss. 5, pp. 399-440
Open Access | Times Cited: 32
Ketamine and its two enantiomers in anesthesiology and psychiatry: A historical review and future directions
Kenji Hashimoto, Mingming Zhao, Tingting Zhu, et al.
Journal of Anesthesia and Translational Medicine (2024) Vol. 3, Iss. 3, pp. 65-75
Open Access | Times Cited: 11
Kenji Hashimoto, Mingming Zhao, Tingting Zhu, et al.
Journal of Anesthesia and Translational Medicine (2024) Vol. 3, Iss. 3, pp. 65-75
Open Access | Times Cited: 11
(R)-(-)-Ketamine: The Promise of a Novel Treatment for Psychiatric and Neurological Disorders
Hana Shafique, Julie Demers, Julia Biesiada, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6804-6804
Open Access | Times Cited: 9
Hana Shafique, Julie Demers, Julia Biesiada, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6804-6804
Open Access | Times Cited: 9
Key role of the gut–microbiota–brain axis via the subdiaphragmatic vagus nerve in demyelination of the cuprizone-treated mouse brain
Xingming Wang, Akifumi Eguchi, Yong Yang, et al.
Neurobiology of Disease (2022) Vol. 176, pp. 105951-105951
Open Access | Times Cited: 34
Xingming Wang, Akifumi Eguchi, Yong Yang, et al.
Neurobiology of Disease (2022) Vol. 176, pp. 105951-105951
Open Access | Times Cited: 34
Exploring the multifaceted potential of (R)-ketamine beyond antidepressant applications
Senbing Zhang, Yanzhu Pu, Jianning Liu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 7
Senbing Zhang, Yanzhu Pu, Jianning Liu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 7
Transforming growth factor-β1 mediates the beneficial effects of arketamine on demyelination and remyelination in the brains of cuprizone-treated mice
Mingming Zhao, Tingting Zhu, Dan Xu, et al.
European Journal of Pharmacology (2024) Vol. 985, pp. 177096-177096
Open Access | Times Cited: 6
Mingming Zhao, Tingting Zhu, Dan Xu, et al.
European Journal of Pharmacology (2024) Vol. 985, pp. 177096-177096
Open Access | Times Cited: 6
Effects of arketamine on depression-like behaviors and demyelination in mice exposed to chronic restrain stress: A role of transforming growth factor-β1
Dan Xu, Guilin Liu, Mingming Zhao, et al.
Journal of Affective Disorders (2024) Vol. 367, pp. 745-755
Open Access | Times Cited: 5
Dan Xu, Guilin Liu, Mingming Zhao, et al.
Journal of Affective Disorders (2024) Vol. 367, pp. 745-755
Open Access | Times Cited: 5
Unique Effects of (R)-Ketamine Compared to (S)-Ketamine on EEG Theta Power in Rats
Dóra Pothorszki, Szabolcs Koncz, Dóra Török, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 2, pp. 194-194
Open Access | Times Cited: 4
Dóra Pothorszki, Szabolcs Koncz, Dóra Török, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 2, pp. 194-194
Open Access | Times Cited: 4
Ketamine, Esketamine, and Arketamine: Their Mechanisms of Action and Applications in the Treatment of Depression and Alleviation of Depressive Symptoms
Piotr Kawczak, Igor Feszak, Tomasz Bączek
Biomedicines (2024) Vol. 12, Iss. 10, pp. 2283-2283
Open Access | Times Cited: 1
Piotr Kawczak, Igor Feszak, Tomasz Bączek
Biomedicines (2024) Vol. 12, Iss. 10, pp. 2283-2283
Open Access | Times Cited: 1
Anesthesia Applications In Experimental Neurological Disease Modeling
Ayhan Çetinkaya, Hümeyra Çelik
Düzce Tıp Fakültesi Dergisi (2024) Vol. 26, Iss. S1, pp. 30-35
Open Access
Ayhan Çetinkaya, Hümeyra Çelik
Düzce Tıp Fakültesi Dergisi (2024) Vol. 26, Iss. S1, pp. 30-35
Open Access
Ketamine attenuates kidney damage and depression-like behaviors in mice with cisplatin-induced acute kidney injury
Tianwen Huang, Yangyang He, Ruijuan Cheng, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access
Tianwen Huang, Yangyang He, Ruijuan Cheng, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access
Microbiome depletion by broad-spectrum antibiotics does not influence demyelination and remyelination in cuprizone-treated mice
Rumi Murayama, Guilin Liu, Mingming Zhao, et al.
Pharmacology Biochemistry and Behavior (2024), pp. 173946-173946
Open Access
Rumi Murayama, Guilin Liu, Mingming Zhao, et al.
Pharmacology Biochemistry and Behavior (2024), pp. 173946-173946
Open Access
Arketamine: a scoping review of its use in humans
Gustavo C. Leal, Isabel Lima-Araújo, David G. Roiter, et al.
European Archives of Psychiatry and Clinical Neuroscience (2024)
Closed Access
Gustavo C. Leal, Isabel Lima-Araújo, David G. Roiter, et al.
European Archives of Psychiatry and Clinical Neuroscience (2024)
Closed Access
Arketamine alleviates cognitive impairments and demyelination in mice with postoperative cognitive dysfunction via TGF-β1 activation
Tingting Zhu, Mingming Zhao, Dan Xu, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 136, pp. 111228-111228
Open Access
Tingting Zhu, Mingming Zhao, Dan Xu, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 136, pp. 111228-111228
Open Access
